Most Recent
The federal government may be hit with a class action over biosecurity breaches that allegedly led to the 2016 outbreak of white spot disease in South-East Queensland that decimated the region's commercial prawn industry.
Fertility clinic Monash IVF says there are "serious questions" about whether a class action that accuses it of destroying viable embryos was validly commenced as a class action.
A group representing insurers has filed another test case over pandemic coverage in business interruption policies, following a landmark loss in a test case concerning an infectious disease exclusion that could cost insurers $10 billion.
The first ever application for a group costs order will be heard in class actions against ANZ and Westpac, and the judge weighing the application has urged the parties to think carefully about the evidence they will submit in support of their bid for a cut of any settlement or judgment.
For two and a half years, law firm Baker McKenzie represented a client in class action litigation over allegedly defective pelvic mesh products that did not exist, a court has heard.
The rejection of a $27 million settlement offer in a class action over American Medical Systems' pelvic mesh products may be included in a proposed opt out notice, with a judge mulling whether to inform group members about a little used law which allows one lead applicant to take over from another.
Food and beverage manufacturer Freedom Foods and accounting giant Deloitte have been hit with a second class action by irate investors seeking compensation for "accounting errors" that led to a $590 million write-down in November last year.
Murray Goulburn insurer AIG Australia says it should not have to pay 20 per cent of a $42 million class action settlement reached by the dairy cooperative, arguing on Tuesday that the class action claims failed to satisfy the definition of a "securities claim" in its insurance policy.
A royal commission has been established in Victoria to look into whether Crown Melbourne is suitable to hold a casino licence in the state, following a damning report from the NSW gaming authority.
Pharmacy giant Priceline is the target of an "imminent" class action, with a group of dissatisfied franchisees accusing the company of exercising an "overly prescriptive" level of control over its franchises and fettering profitability.